Qassim University   Report issue

Academic/Hospital Phase 1
Founded: Qassim Saudi Arabia (2004)

Organization Overview

First Clinical Trial
2016
NCT04677764
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Assistant Prof. at Pharmaceutics dept., Faculty of Pharmacy, Qassim University, KSA | College of medical rehabilitation, Qassim University | Qassim University

Active Ingredients

Drugs in Phase 1 Trials (3)

ginkgo biloba (1 trial)

pomegranate (1 trial)

veldoreotide (1 trial)

Drugs in Other Trials (3)

glucagon (1 trial)

glucose (1 trial)

olive oil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 1)

Skin Diseases (Phase 1)

Skin Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 11
  • # of Trial APIs: 6